Protection of Rat Myocardium by Mitogenic and Non-Mitogenic Fibroblast Growth Factor During Post-Ischemic Reperfusion

References

• Babbs C. F. Reperfusion injury of postischemic tissues. Ann. Emerg. Med. 1988; 17: 1148–1157
   PubMedGoogle Scholar
• Baird A., Mormède P., Ying S. Y., Wehrenberg W. B., Ueno N., Ling N., Guillemin R. A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion. Proc. Natl. Acad. Sci. USA 1985; 82: 5545–5549
   PubMed Web of Science ®Google Scholar
• Baird A., Hsueh A. J. W. Fibroblast growth factor as an intraovarian hormone: differential regulation of steroidogenesis by an angiogenic factor. Regul. Peptides 1986; 16: 243–250
   PubMedGoogle Scholar
• Banai S., Jaklitsch M. T., Casscells W., Shou M., Shrivastav S., Correa R., Epstein S. E., Unger E. F. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ. Res. 1991; 69: 76–85
   PubMed Web of Science ®Google Scholar
• Barrios V., Cuevas P., Asin-Cardiel E., Cuevas B., Muñoz-Willery I., Giménez-Gallego G. Vasodilatory effect of fibroblast growth factors in pig precontracted coronary arteries. Eur. Heart J. 1992; 13: 291
   PubMedGoogle Scholar
• Boddeke E., Hugtenburg J., Jap W., Heynis J., van Zwieten P. New anti-ischaemic drugs: cytoprotective action with no primary haemodynamic effects. Trends Pharmacol. Sci. 1989; 10: 397–400
   PubMedGoogle Scholar
• Bolli R., Triana J. F., Jeroudi M. O. Prolonged impairment of coronary vasodilation after reversible ischemia. Circ. Res. 1990; 67: 332–343
   PubMed Web of Science ®Google Scholar
• Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding. Anal. Biochem. 1976; 72: 246–254
   Google Scholar
• Braunwald E., Kloner R. A. Myocardial reperfusion: a double-edged sword?. J. Clin. Invest. 1985; 76: 1713–1719
   PubMed Web of Science ®Google Scholar
• Casscells W., Speir E., Sasse J., Klagsbrun M., Allen P., Lee M., Calvo B., Chiba M., Haggroth L., Folkman J., Epstein S. E. Isolation, characterization, and localization of heparin-binding growth factors in the heart. J. Clin. Invest. 1990; 85: 433–441
   PubMed Web of Science ®Google Scholar
• Chilian W. M., Eastham C. L., Marcus M. L. Microvascular distribution of coronary vascular resistance in the beating left ventricle. Am. J. Physiol 1986; 251: H779–H788
   PubMed Web of Science ®Google Scholar
• Cole W. C., McPherson C. D., Sontag D. ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ. Res. 1991; 69: 571–581
   PubMed Web of Science ®Google Scholar
• Cuevas P., Carceller F., Ortega S., Zazo M., Nieto I., Giménez-Gallego G. Hypotensive activity of fibroblast growth factor. Science 1991; 254: 1208–1210
   PubMed Web of Science ®Google Scholar
• Cuevas P., González A. M., Carceller F., Baird A. Vascular response to basic fibroblast growth factor when infused onto the normal adventitia or into the injured media of the rat carotid artery. Circ. Res. 1991b; 69: 360–372
   PubMed Web of Science ®Google Scholar
• Daut J., Maier-Rudolph W., von Beckerath N., Mehrke G., Gunther K., Goedel-Meinen L. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 1990; 247: 1341–1344
   PubMed Web of Science ®Google Scholar
• Edelman E. R., Nugent M. A., Smith L. T., Karnovsky M. J. Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J. Clin. Invest 1992; 89: 465–472
   PubMed Web of Science ®Google Scholar
• Editorial. Reperfusion injury after thrombolytic therapy for acute myocardial infarction. Lancet; September 1989; 16: 655–657
   Google Scholar
• Escande D., Cavero I. K+ channel openers and “natural” cardioprotection. Trends Phamacol. Sci. 1992; 13: 269–272
   PubMed Web of Science ®Google Scholar
• Fina M., Baird A., Ryan A. Direct application of basic fibroblast growth factor improves tympanic membrane perforation healing. Laringoscope 1993; 103: 804–809
   PubMedGoogle Scholar
• Ganote C. E., Humphrey S. M. Effects of anoxic or oxygenated reperfusion in globally ischemic, isovolumic, perfused rat hearts. Am. J. Pathol. 1985; 120: 129–145
   PubMedGoogle Scholar
• Giménez-Gallego G., Cuevas P. Fibroblast growth factor, a protein with a broad spectrum of biological activities. Neurol. Res. 1994; 16: 181–183
   PubMedGoogle Scholar
• Gutierrez-Diaz J. A., Cuevas P., Reimers D., Dujovny M., Diaz F. G., Ausman J. I. Quantitative electron microscopic study of calcium accumulation in cerebral ischemia mitochondria. Surg. Neurol. 1985; 24: 67–72
   PubMedGoogle Scholar
• Imamura T., Engleka K., Zhan X., Tokita Y., Forough R., Roeder D., Jackson A., Maier J. A. M., Hla T., Maciag T. Recovery of mitogenic activity of a growth factor mutant with a nuclear translcation sequence. Science 1990; 249: 1567–1571
   PubMed Web of Science ®Google Scholar
• Jeremy R. W., Stahl L., Gillinov M., Litt M., Aversano T. R., Becker L. C. Preservation of coronary reserve in stunned myocardium. Am. J. Physiol. 1989; 256: H1303–H1310
   PubMed Web of Science ®Google Scholar
• Kardami E., Fandrich R. R. Basic fibroblast growth factor in atria and ventricles of the vertebrate heart. J. Cell Biol. 1989; 109: 1865–1875
   PubMed Web of Science ®Google Scholar
• Kardami E., Padua R. R., Pasumarthi B. S., Liu L., Doble B. W., Davey S. E., Cattini P. A. Basic fibroblast growth factor in cardiac myocytes: expression and effects. Growth factors and the cardiovascular system, P. Cummins. Kluver Academic Publishers, Boston 1993; 54–75
   Google Scholar
• Kim Y. D., Fomsgaard J. S., Heim K. F., Ramwell P. W., Thomas G., Kagan E., Moore B. S., Coughlin S. S., Kuwuhara M., Analuei A., Myers A. K. Brief ischemia-reperfusion induces stunning of endothelium in canine coronary artery. Circulation 1987; 85: 1473–148
   Google Scholar
• Kjekshus J. K., Sober B. E. Depressed myocardial creatine phosphokinase activity following experimental myocardial infarction in rabbit. Circ. Res. 1979; 27: 403–409
   Google Scholar
• Lefer A. M., Tasao P., Aoki N., Palladino M. A., Jr. Mediation of cardioprotection by transforming growth factor-B. Science 1990; 249: 61–64
   PubMed Web of Science ®Google Scholar
• Li Y., Kloner A. The cardioprotective effects of ischemic “preconditioning” are not mediated by adenosine receptors. Circulation 1993; 87: 1642–1648
   PubMedGoogle Scholar
• Lindner V., Lappi D. A., Baird A., Majack R. A., Reidy M. A. Role of basic fibroblast growth factor in vascular lesion formation. Circ. Res. 1991; 68: 106–113
   PubMed Web of Science ®Google Scholar
• Lindner V., Reidy M. A. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl. Acad. Set. USA 1991; 88: 3739–3743
   PubMed Web of Science ®Google Scholar
• Miranda A. F., Babiss L. E., Fisher P. B. Measurement of the effect of interferons on cellular differentiation of human skeletal muscle cells. Methods in Enzymology, S. Pestka. Academic Press, Orlando 1986; 119: 619–628
   Google Scholar
• Moscatelli D., Presta M., Rifkin D. B. Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis and migration. Proc. Natl. Acad. Sci. USA 1986; 83: 2091–2095
   PubMed Web of Science ®Google Scholar
• Nayler W. G., Panagiotopoulos S., Elz J. S., Daly M. J. Calcium-mediated damage during post-ischaemic reperfusion. J. Mol. Cell Cardiol 1988; 20(Suppl II)41–54
   PubMedGoogle Scholar
• Nichols W. W., Mehta J. L., Donnelly W. H., Lawson D., Thomson L., ter Riet M. Reduction in coronary vasodilator reserve following coronary occlusion and reperfusion in anesthetized dog: Role on endothelium-derived relaxing factor, myocardial neutrophil infiltration and pro-taglandins. J. Mol. Cell. Cardiol. 1988; 20: 943–954
   PubMedGoogle Scholar
• Opie L. H., Phil D. Reperfusion injury and its pharmacologic modification. Circulation 1989; 80: 1049–1062
   PubMed Web of Science ®Google Scholar
• Ortega S., Schaeffer M. T., Soderman D., DiSalvo J., Line-Meyer D. L., Giménez-Gallego G., Thomas K. A. Conversion of cysteine to serine residues alters the activity, stability and heparin dependence of acidic fibroblast growth factor. J. Biol. Client. 1991; 266: 5842–5846
   Google Scholar
• Presta M., Moscatelli D., Joseph-Silverstein J., Rifkin D. B. Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis and migration. Mol. Cell Biol. 1986; 6: 4060–4066
   PubMed Web of Science ®Google Scholar
• Quast U., Cook N. S. Moving together: K+ channel openers and ATP-sensitive K+ channels. Trends Pharmacol. Sci. 1989; 10: 431–435
   PubMed Web of Science ®Google Scholar
• Quinkler W., Maasberg M., Bernotat-Danielowski S., Luthe N., Sharma H. S., Schaper W. Isolation of heparin-binding growth factors from bovine, porcine and canine hearts. Eur. J. Biochem. 1989; 181: 67–73
   PubMedGoogle Scholar
• Reimer K. A., Murry C. E., Richard V. J. The role of neutrophils and free radicals in the ischemic-reperfused heart: why the confusion and controversy?. J. Mol. Cell Cardiol. 1989; 21: 1225–1239
   PubMed Web of Science ®Google Scholar
• Rosengart T. K., Kuperschmid J. P., Maciag T., Clark R. Parmacokinetics and Distribution of heparin-binding growth factor I (endothelial cell growth factor) in the rat. Circ. Res. 1989; 64: 227–234
   PubMed Web of Science ®Google Scholar
• Saliba M. J., Covell J. W., Bloor C. M. Effects of heparin in large doses on the extent of myocardial ischemia after acute coronary occlusion in the dog. Am. J. Cardiol. 1976; 37: 599–604
   PubMedGoogle Scholar
• Schmid-Schöbein G. W. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed. Proc. 1987; 46: 2397–2401
   PubMedGoogle Scholar
• Schweigerer L. Basic fibroblast growth factor as a wound healing hormone. Trends Pharmacol. Sci. 1988; 9: 427–428
   PubMed Web of Science ®Google Scholar
• Seno M., Sasada R., Lwane M., Sudo K., Kurokawa T., Ito K., Igarashi K. Stabilizing basic fibroblast growth factor using protein engineering. Biochem. Biophys. Res. Commun. 1988; 151: 701–708
   PubMed Web of Science ®Google Scholar
• Stahl L. D., Aversano T. R., Becker L. C. Selective enhancement of function of stunned myocardium by increased flow. Circulation 1986; 74: 843–851
   PubMedGoogle Scholar
• Sullivan A. T., Baker D. J., Drew G. M. Effect of calcium channel blocking agents on infarct size after ischaemia-reperfusion in anaesthetised pigs: relationship between cardioprotection and cardiodepression. J. Cardiovasc. Pharmacol. 1991; 17: 707–716
   PubMedGoogle Scholar
• Thomas K. A., Giménez-Gallego G. Fibroblast growth factors: broad spectrum mitogens with potent angiogenic activity. Trends Biochem. Sci. 1986; 11: 1–4
   Google Scholar
• Thomas K. A., Rios-Candelore M., Giménez-Gallego G., DiSalvo J., Bennett C., Rodkey J., Fitzpatrick S. Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc. Natl. Acad. Sci. USA 1985; 82: 6409–6413
   PubMed Web of Science ®Google Scholar
• Thompson J. A., Haudenschild C. C., Anderson K. D., DiPietro J. M., Anderson W. F., Maciag T. Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo. Proc. Natl. Acad. Sci. USA 1989; 86: 7928–7932
   PubMed Web of Science ®Google Scholar
• Unger E. F., Banai S., Shou M., Lazarus D. F., Jaklitsch M., Scheinowitz M., Correa R., Klingbeil C., Epstein S. E. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am. J. Physiol. 1994; 266: H1588–H1595
   PubMed Web of Science ®Google Scholar
• VanBenthuysen K. M., McMurtry I. F., Horwitz L. D. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J. Clin. Invest. 1987; 79: 265–274
   PubMedGoogle Scholar
• von Beckerath N., Cyrys S., Dischner A., Daut J. Hypoxic vasodilatation in isolated, perfused guinea-pig heart: an analysis of the underlying mechanisms. J. Physiol. 1991; 442: 297–319
   PubMedGoogle Scholar
• Yanagisawa-Miwa A., Uchida Y., Nakamura F., Tomaru T., Kido H., Kamijo T., Sugimoto T., Kaji K., Utsuyama M., Kurashima C., Ito H. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992; 257: 1401–1403
   PubMed Web of Science ®Google Scholar
• Yang W. D., de Bono D. P. Vascular endothelial growth factor modulates endothelial resistance to hydrogen peroxide. Eur. Heart J. 1996; 17(suppl)190
   Google Scholar
• Zazo M., Lozano R. M., Ortega S., Varela J., Díaz-Orejas R., Ramirez J. M., Giménez-Gallego G. High-level synthesis in Escherichia coli of shortened and full-length human acidic fibroblast growth factor and purification in a form stable in aqueous solutions. Gene 1992; 113: 231–238
   PubMed Web of Science ®Google Scholar